ArticleJournal of diabetes science and technology2017

Treatment Outcomes and Tolerability Following Initiation of GLP-1 Receptor Agonists Among Type 2 Diabetes Patients in Primary Care Practices in Germany.

Qing Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.